independent pharmacy channel, totaling approximately 4.99 million baht which increased by 2.24 million baht year-on-year due to increased sales. Some expenses have dropped i. e. sales promotion expenses, booth
million. Q4/2018, the Company and its subsidiary had independent specialist to evaluate and reclassified employee benefit payables as well as recognised actuarial loss Baht 0.44 million deductible deferred
neither undertake any responsibility for its accuracy nor be held liable for any loss or damages arising from or related to its use. ---------------------- Notification of the Capital Market Supervisory
the lowest price from 2 independent appraisal companies, who are independent appraisers authorized by the SEC, from machineries evaluation as well as negotiation and agreement between the Parties. The
Costs - - 9.35 72.09 Administrative expenses, impairment finance costs and share of loss from associates 28.78 484.51 15.59 120.20 Management benefit expenses 5.21 87.71 5.78 44.56 Profit (Loss) before
. Assoc. Prof. Dr.Ekaporn Rakkwamsuk Director 4. Ms. Jatechanya Boonchaleo Director 5. Dr. Aphichat Samoon Independent Director 6. Asst. Prof. Dr. Chalermkiat Wongvanichtawee Independent Director 7
Company's operating results in the third quarter ended September 30, 2018 has loss in amount of Baht 9.64 million (loss per share Bath 0.96), compared to the same period of last year which had loss of Baht
resolutions as following: (1) Approved the Balance Sheet and the Profits and Loss Statement as of 31 December 2019 (2) Approved the dividend payment from the company’s performance of the period 1 July – 31